| Hormone Receptor-Negative | Hormone Receptor-Positive |  | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
 | 2000–2009 | 2010–2019 |  | 2000–2009 | 2010–2019 |  |  | ||||
Variable | % | OR | % | OR (95% CI) | P | % | OR | % | OR (95% CI) | P | Â |
Age | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
≥ 50 | 75.4 | 1 | 79.3 | 1.25(1.01–1.53) | 0.037 | 74.8 | 1 | 73.4 | 1.06(0.71–1.57) | 0.759 |  |
Race/Ethnicity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Black | 13.1 | 1 | 15.6 | 1.18(0.92–1.51) | 0.205 | 16.7 | 1 | 15.8 | 1.05(0.67–1.67) | 0.841 |  |
White | 68.5 | 1 | 64.2 | 0.78(0.65–0.94) | 0.009 | 67.6 | 1 | 59.3 | 0.72(0.51–1.02) | 0.066 |  |
Hispanic | 12.3 | 1 | 12.6 | 1.13(0.87–1.48) | 0.359 | 8.1 | 1 | 12.6 | 1.40(0.80–2.56) | 0.251 |  |
Other | 6.1 | 1 | 7.5 | 1.37(0.97–1.94) | 0.076 | 7.6 | 1 | 12.3 | 1.60(0.91–2.97) | 0.116 |  |
Node Statusa | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Positive | 22.9 | 1 | 17.9 | 0.72(0.58–0.90) | 0.003 | 27.1 | 1 | 22.5 | 0.69(0.47–1.01) | 0.056 |  |
Negative | 70.4 | 1 | 75.3 | 1.33(1.10–1.62) | 0.004 | 64.3 | 1 | 68.9 | 1.31(0.92–1.85) | 0.128 |  |
T Stage | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
T0&T1 | 23.0 | 1 | 25.8 | 1.16(0.94–1.42) | 0.167 | 33.8 | 1 | 26.2 | 0.63(0.44–0.92) | 0.015 |  |
T2 | 54.4 | 1 | 49.2 | 0.81(0.68–0.96) | 0.016 | 44.3 | 1 | 51.6 | 1.35(0.98–1.87) | 0.069 |  |
T3 | 15.9 | 1 | 17.3 | 1.11(0.88–1.40) | 0.379 | 14.3 | 1 | 15.0 | 1.10(0.70–1.78) | 0.686 |  |
T4 | 6.7 | 1 | 7.7 | 1.22(0.87–1.72) | 0.258 | 7.6 | 1 | 7.1 | 1.08(0.58–2.10) | 0.810 |  |